How 23andMe's test for a breast-cancer gene can save lives—but lead consumers down a tricky path
June 24, 2018 at 12:22 PM EDT
The FDA cleared 23andMe to test for three BRCA mutations with its at-home ancestry tests earlier this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|